Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in non-AMD choroidal neovascularization
NCT00370786Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2005
- Primary completion
- Nov 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in choroidal neovascularization (CNV), sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00370786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370786.